Discrimination of patients with Parkinson's disease and healthy control subjects using MRI

被引：0
|
作者：
Menke, R. A.
Scholz, J.
Miller, K. L.
Zarei, M.
机构：
来源：
MOVEMENT DISORDERS | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S200 / S200
页数：1
相关论文
共 50 条
  • [1] Discrimination between healthy subjects and patients with Parkinson's disease using the PLM test and a levodopa challenge test
    Zackrisson, T.
    Eriksson, B.
    Holmberg, B.
    Johnels, B.
    Thorlin, T.
    MOVEMENT DISORDERS, 2009, 24 : S288 - S288
  • [2] The motor control output forming in healthy subjects and Parkinson's Disease patients
    Romanov, SP
    Pchelin, MG
    BASAL GANGLIA AND THALAMUS IN HEALTH AND MOVEMENT DISORDERS, 2001, : 293 - 305
  • [3] The interlocking finger test in patients with Parkinson's disease and healthy subjects
    Souza, Carolina Pinto
    Oliveira, Guiomar Nascimento
    Foss, Maria Paula
    Tumas, Vitor
    JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 29 : 145 - 148
  • [4] Population Pharmacokinetic Analysis of Istradefylline in Healthy Subjects and in Patients With Parkinson's Disease
    Knebel, William
    Rao, Niranjan
    Uchimura, Tatsuo
    Mori, Akihisa
    Fisher, Jeannine
    Gastonguay, Marc R.
    Chaikin, Philip
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (01): : 40 - 52
  • [5] Characteristics of cognitive function in patients with Parkinson's disease: a comparison with healthy subjects
    Morita, K
    Shoji, H
    Yamamoto, H
    Nishiura, S
    Shoji, Y
    Matuoka, T
    Maeda, H
    UNVEILING THE MYSTERY OF THE BRAIN: NEUROPHYSIOLOGICAL INVESTIGATION OF THE BRAIN FUNCTION, 2005, 1278 : 344 - 347
  • [6] Discrimination of EMG and acceleration measurements between patients with Parkinson's disease and healthy persons
    Rissanen, Saara M.
    Kankaanpaa, Markku
    Tarvainen, Mika P.
    Meigal, Alexander
    Nuutinen, Juho
    Jakala, Pekka
    Airaksinen, Olavi
    Karjalainen, Pasi A.
    2010 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2010, : 4878 - 4881
  • [7] Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson's disease
    Garcia-Martin, Elena
    Pablo, Luis E.
    Bambo, Maria P.
    Alarcia, Raquel
    Polo, Vicente
    Larrosa, Jose M.
    Vilades, Elisa
    Cameo, Beatriz
    Orduna, Elvira
    Ramirez, Teresa
    Satue, Maria
    PLOS ONE, 2017, 12 (05):
  • [8] Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
    Marina Senek
    Dag Nyholm
    Elisabet I. Nielsen
    European Journal of Clinical Pharmacology, 2018, 74 : 1299 - 1307
  • [9] Comparison of retinal fluorescence lifetime between patients with Parkinson's disease and healthy subjects
    Miura, Yoko
    Rauenbusch, Kim
    Prasuhn, Jannik
    Brueggemann, Norbert
    Grisanti, Salvatore
    Sonntag, Svenja Rebecca
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [10] Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson's disease patients
    Senek, Marina
    Nyholm, Dag
    Nielsen, Elisabet I.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (10) : 1299 - 1307
12345